CLOV logo

CLOV

Profile

Full Name

Clover Health Investments, Corp.

Ticker Symbol

CLOV

Exchange

NASDAQ

Sector

Healthcare

Industry

Healthcare Plans

Country

United States

IPO

June 12, 2020

Indexes

Not included

Website

http://www.cloverhealth.com

Employees

570

Key Details

Price

$3.72(+1.64%)

Market cap

Last Dividend

$0.10

TTM Dividend yield

-

Annual revenue

$1.37B(+8.77% YoY)

Annual EPS

-$0.08(+82.22% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.72
CLOV price is $3.72

30-Day Relative Volume

0.78
CLOV 30-day relative volume is 0.78

Price Performance

Price Most recent change

+1.64%
CLOV price was up +1.64% on Apr 15, 2025

Price YTD change

+18.1%
CLOV price is up +18.1% since January 1st

Price 1-year change

+484.91%
CLOV price is up +484.91% year-on-year

Price 3-year change

+19.61%
CLOV price is up +19.61% over the past 3 years

Price Range

Price All-time high

$28.85
CLOV price is currently -87.11% below its historical high of $28.85

Price 3-year low

$0.61
CLOV price is currently +513.86% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.90B
CLOV market capitalization is $1.90 billion

Market cap 3-year change

+29.12%
CLOV market capitalization is up +29.12% over the past 3 years

Market cap All-time high

$9.04B
CLOV market capitalization is currently -78.97% below its historical high of $9.04 billion

Market cap sector rank

83.14%
CLOV market capitalization is higher than 83.14% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.05%
CLOV shares outstanding is up +3.05% year-on-year

Shares Outstanding 3-Year Change

+7.95%
CLOV shares outstanding is up +7.95% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.87
CLOV beta is 0.87

200-day SMA

$3.28
CLOV price is currently +13.34% above its 200-day simple moving average

50-day SMA

$3.90
CLOV price is currently -4.57% below its 50-day simple moving average

RSI

52.00
CLOV 14-day relative strength index is 52.00

Volume

0.78
CLOV 30-day relative volume is 0.78

ATR

$0.24
CLOV average true range is $0.24

10-day Historical Volatility

61.16%
CLOV 10-day historical volatility is 61.16%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.10
CLOV last dividend was $0.10 per share, with an ex-dividend date of August 23, 2021

Next Dividend

-
CLOV next dividend has not yet been announced

Dividend per share

Dividend per share

-
CLOV annual dividend per share value is unknown

Dividend per share Sector Rank

-
CLOV annual dividend per share is unknown

Dividend per share 1-Year Change

-
CLOV annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
CLOV annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
CLOV annual dividend yield value is unknown

Dividend yield Sector Rank

-
CLOV annual dividend yield is unknown

Other

Payout ratio

-
CLOV annual payout ratio value is unknown

Dividends paid

-
CLOV annual dividends paid value is unknown

Free cash flow

$33.29M
CLOV annual free cash flow is $33.29 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.37B
CLOV annual revenue is $1.37 billion

Revenue Analysts estimate

$1.86B
CLOV annual revenue is currently -26.47% lower than the consensus analysts' forecast

Revenue 1-year change

+8.77%
CLOV annual revenue is up +8.77% year-on-year

Revenue Sector rank

83.09%
CLOV annual revenue is higher than 83.09% of companies in Healthcare sector

EPS

EPS

-$0.08
CLOV annual earnings per share is -$0.08

EPS Analysts estimate

-$0.20
CLOV annual earnings per share is currently -60.00% lower than the consensus analysts' forecast

EPS 1-year change

+82.22%
CLOV annual earnings per share is up +82.22% year-on-year

EPS Sector rank

81.06%
CLOV annual earnings per share is higher than 81.06% of companies in Healthcare sector

Profit

Gross profit

$364.80M
CLOV annual gross profit is $364.80 million

Gross margin

26.61%
CLOV annual gross profit margin is 26.61%

Operating profit

-$45.46M
CLOV annual operating income is -$45.46 million

Operating margin

-3.32%
CLOV annual operating profit margin is -3.32%

Net income

-$43.01M
CLOV annual net profit is -$43.01 million

Net margin

-3.14%
CLOV annual net profit margin is -3.14%

Expenses

Total expenses

$1.42B
CLOV annual total expenses is $1.42 billion

Operating expenses

$410.26M
CLOV annual total operating expenses is $410.26 million

Cost of goods sold

$1.01B
CLOV annual cost of goods sold is $1.01 billion

Selling, general & administrative expenses

$408.93M
CLOV annual SGA is $408.93 million

Depreciation and amortization

$1.33M
CLOV annual depreciation & amortization is $1.33 million

Interest expense

$0.00
CLOV annual interest expense is $0.00

Income tax

-
CLOV annual income tax value is unknown

EBIT & EBITDA

EBIT

-$46.27M
CLOV annual earnings before interest & taxes is -$46.27 million

EBITDA

-$44.94M
CLOV annual EBITDA is -$44.94 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$580.74M
CLOV annual total assets is $580.74 million

Non current assets

$237.62M
CLOV annual long term assets is $237.62 million

Current assets

$343.12M
CLOV annual total current assets is $343.12 million

Cash and cash equivalents

$194.54M
CLOV annual cash & cash equivalents is $194.54 million

Accounts receivable

-
CLOV annual accounts receivable value is unknown

Inventory

-
CLOV annual inventory value is unknown

Liabilities

Total liabilities

$239.60M
CLOV annual total liabilities is $239.60 million

Long term liabilities

$26.08M
CLOV annual total long term liabilities is $26.08 million

Current liabilities

$213.52M
CLOV annual total current liabilities is $213.52 million

Accounts payable

$34.56M
CLOV annual accounts payable is $34.56 million

Debt

Total debt

$0.00
CLOV annual total debt is $0.00

Total debt 1-year change

0%
CLOV {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
CLOV annual long term debt value is unknown

Short term debt

-
CLOV annual short term debt value is unknown

Equity & Capital

Shareholders equity

$341.14M
CLOV annual stockholders equity is $341.14 million

Book value

$341.14M
CLOV annual book value is $341.14 million

Retained earnings

-$2.20B
CLOV annual retained earnings is -$2.20 billion

Working capital

$129.61M
CLOV annual working capital is $129.61 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$34.84M
CLOV annual cash flow from operations is $34.84 million

Cash from operations 1-year change

+124.09%
CLOV annual cash flow from operations is up +124.09% year-on-year

Cash from investing

$565.00K
CLOV annual cash flow from investing activities is $565.00 thousand

Cash from investing 1-year change

-99.6%
CLOV annual cash flow from investing activities is down -99.6% year-on-year

Cash from financing

-$17.36M
CLOV annual cash flow from financing activities is -$17.36 million

Cash from financing 1-year change

-242.43%
CLOV annual cash flow from financing activities is down -242.43% year-on-year

CAPEX

CAPEX

$1.56M
CLOV annual capital expenditures is $1.56 million

CAPEX 1-year change

+166.44%
CLOV annual capital expenditures is up +166.44% year-on-year

Free Cash Flow

Free cash flow

$33.29M
CLOV annual free cash flow is $33.29 million

Free cash flow 1-year change

+122.92%
CLOV annual free cash flow is up +122.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

26.61%
CLOV annual gross profit margin is 26.61%

Operating margin

-3.32%
CLOV annual operating profit margin is -3.32%

Net margin

-3.14%
CLOV annual net profit margin is -3.14%

ROA & ROE

ROA

-7.47%
CLOV annual return on assets is -7.47%

ROE

-13.71%
CLOV annual return on equity is -13.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CLOV price to earnings ratio value is unknown

PE ratio Sector rank

-
CLOV price to earnings ratio is unknown

PB Ratio

PB ratio

5.57
CLOV price to book ratio is 5.57

PB ratio Sector rank

84.61%
CLOV price to book ratio is higher than 84.61% of companies in Healthcare sector

PS Ratio

PS ratio

1.39
CLOV price to sales ratio is 1.39

PS ratio Sector rank

34.1%
CLOV price to sales ratio is higher than 34.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.71B
CLOV enterprise value is $1.71 billion

Enterprise value Sector rank

80.33%
CLOV enterprise value is higher than 80.33% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-38.67
CLOV EV/EBITDA is -38.67

EV/EBITDA Sector rank

3.65%
CLOV EV/EBITDA is higher than 3.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.61
CLOV annual current ratio is 1.61

Quick ratio

-
CLOV annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CLOV annual debt to equity ratio is 0.00

Interest coverage ratio

-
CLOV annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CLOV piotroski f-score value is unknown

Altman Z-Score

1.81
CLOV altman z-score is 1.81

Analyst ratings

Recent major analysts updates

Mar 3, 25 Canaccord Genuity
Buy
Dec 17, 24 Craig-Hallum
Buy
Oct 7, 24 UBS
Neutral
Aug 11, 23 Citigroup
Neutral
Mar 6, 23 Credit Suisse
Underperform
Mar 6, 23 Canaccord Genuity
Buy
Nov 16, 22 Citigroup
Neutral
Nov 8, 22 SVB Leerink
Market Perform
Aug 9, 22 Credit Suisse
Underperform
Aug 9, 22 Citigroup
Neutral

Institutional Ownership

Similar stocks

Belite Bio (BLTE)
BHVN logo
Biohaven (BHVN)
MIRM logo
Mirum Pharmaceuticals (MIRM)
APGE logo
Apogee Therapeutics (APGE)
LMAT logo
LeMaitre Vascular (LMAT)
LIVN logo
LivaNova (LIVN)
Metsera (MTSR)
DNLI logo
Denali Therapeutics (DNLI)
TARS logo
Tarsus Pharmaceuticals (TARS)
  • What is the ticker symbol for Clover Health Investments?
  • Does Clover Health Investments pay dividends?
  • What sector is Clover Health Investments in?
  • What industry is Clover Health Investments in?
  • What country is Clover Health Investments based in?
  • When did Clover Health Investments go public?
  • Is Clover Health Investments in the S&P 500?
  • Is Clover Health Investments in the NASDAQ 100?
  • Is Clover Health Investments in the Dow Jones?
  • When was Clover Health Investments's last earnings report?
  • When does Clover Health Investments report earnings?
  • Should I buy Clover Health Investments stock now?

What is the ticker symbol for Clover Health Investments?

The ticker symbol for Clover Health Investments is NASDAQ:CLOV

Does Clover Health Investments pay dividends?

No, Clover Health Investments does not pay dividends

What sector is Clover Health Investments in?

Clover Health Investments is in the Healthcare sector

What industry is Clover Health Investments in?

Clover Health Investments is in the Healthcare Plans industry

What country is Clover Health Investments based in?

Clover Health Investments is headquartered in United States

When did Clover Health Investments go public?

Clover Health Investments's initial public offering (IPO) was on June 12, 2020

Is Clover Health Investments in the S&P 500?

No, Clover Health Investments is not included in the S&P 500 index

Is Clover Health Investments in the NASDAQ 100?

No, Clover Health Investments is not included in the NASDAQ 100 index

Is Clover Health Investments in the Dow Jones?

No, Clover Health Investments is not included in the Dow Jones index

When was Clover Health Investments's last earnings report?

Clover Health Investments's most recent earnings report was on Feb 27, 2025

When does Clover Health Investments report earnings?

The next expected earnings date for Clover Health Investments is May 6, 2025

Should I buy Clover Health Investments stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page